CHOICE-Global

CHOICE-Global is an international independent academic project focused on advancing research on allergen immunotherapy. This study aims to identify the key drivers for the prescription and selection of allergen immunotherapy in real-life clinical settings for patients, adults and children living with respiratory allergic diseases.

CHOICE-Global project includes the participation of 474 doctors currently practicing clinical allergy in 20 countries. These countries are Argentina, Australia, China, Colombia, Costa Rica, Ecuador, El Salvador, France, Germany, Honduras, Italy, Japan, Kingdom of Saudi Arabia, Lebanon, Mexico, Peru, Qatar, Russia, Spain and the USA.

This group has collected clinical information from 11,635 patients from eight regions around the globe. Currently, the group is working on the statistical analysis of the data which will be presented and discussed with all national coordinators during the CHOICE-Global meeting which will be held in Doha, Qatar on 15 and 16 November 2025.

The CHOICE-Global group is under the representation of Consultoría Alergia y Academia MACZ 2413, S.A and has a Costa Rican legal registration number 3-101- 691293. CHOICE-Global is headquartered in San José, Costa Rica and it is directed by Prof Dr Moisés A. Calderón-Zapata, Emeritus Professor in Internal Medicine and Consultant in Allergy and Clinical Immunology.

CHOICE-GLOBAL Publications

• Rodriguez del Rio P, Caimmi D, Rico Nieto P, Vidal C, Moreno C et al. Demoly P and Calderón MA. CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts. World Allergy Organization Journal. 2023-06; Journal article. DOI: 10.1016/ j.waojou.2023.100791
  
  
• Caimmi D, Pablo Rodríguez del Río P, Rico P, Vidal C; Moreno C, Casale Thomas B, Demoly P and Calderón MA. Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice: Methodology. World Allergy Organization Journal. 2023-02; Journal article. DOI: 10.1016/j.waojou.2023.100749
  
  
• Rodriguez del Rio P, Caimmi D, Rico Nieto P, Vidal C, Moreno C et al. and Demoly P and Calderón MA. Real‐life report of allergen immunotherapy management during the COVID‐19 outbreak in France and Spain Clinical & Experimental Allergy; 2022-01. Journal article. DOI: 10.1111/cea.14043

CHOICE-Global workshop aims

• To present and discuss full statistical analysis of CHOICE-Global data.
• To discuss and plan future publications of CHOICE-Global results.
• To discuss and plan future dissemination of CHOICE-Global results.
• To discuss and plan CHOICE-Global follow-up project.

Representing CHOICE-Global Group

• Prof Dr Moises A. Calderon, General Director of CHOICE-Global
• Prof Dr Pascal Demoly, Chair of the Scientific Committee
• Prof Dr Pilar Rico, Co-Chair of the Scientific Committee